Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Is thrombolytic therapy effective in stroke?].

B Mørland1, J A Aarli, E Lund

  • 1Senter for medisinsk metodevurdering, SINTEF Unimed, Oslo.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|May 5, 2000
PubMed
Summary

Thrombolytic treatment for stroke shows uncertain benefits and carries risks like intracranial hemorrhage. Future use requires research protocols to document effects and side effects thoroughly.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)<sup>☆</sup>.

ESMO open·2021
Same author

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Congenital mesoblastic nephroma: a single-centre series.

Annals of the Royal College of Surgeons of England·2019
Same author

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Cartilage hair hypoplasia with cutaneous lymphomatoid granulomatosis.

Clinical and experimental dermatology·2018

Area of Science:

  • Neurology
  • Health Technology Assessment

Background:

  • The Norwegian Centre for Health Technology Assessment evaluated thrombolytic medication for stroke treatment.
  • The assessment included potential impacts on healthcare system organization.